Colgate Palmolive (CL) EBITDA (2009 - 2026)

Colgate Palmolive has reported EBITDA for 18 years, with the latest figure at $1.0 billion in Q2 2026.

• On a quarterly basis, EBITDA fell 5.93% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $3.1 billion, a 26.91% decrease from a year earlier, with the FY2025 full-year figure at $3.3 billion, down 22.54% from the prior year.
• EBITDA was $1.0 billion for Q2 2026 at Colgate Palmolive, up from $964.0 million in the prior quarter.
• The five-year high for EBITDA was $1.1 billion in Q2 2024, with the low at $92.0 million in Q4 2025.
• Average EBITDA over 5 years is $912.8 million, with a median of $1.0 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: EBITDA surged 430.69% in 2023, then sank 91.35% in 2025.
• Over 5 years, EBITDA stood at $202.0 million in 2022, then soared by 430.69% to $1.1 billion in 2023, then retreated by 0.84% to $1.1 billion in 2024, then tumbled by 91.35% to $92.0 million in 2025, then soared by 1004.35% to $1.0 billion in 2026.
• The last three EBITDA figures came in at $1.0 billion (Q2 2026), $964.0 million (Q1 2026), and $92.0 million (Q4 2025), per Business Quant data.